AzTrials
AzTrials

Emergency Service, HospitalNCT04338672

The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients

An observational study of Emergency Service, Hospital and General Surgery, run by Sheba Medical Center at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Since December 2019, when the novel coronavirus disease (Covid-19) spread throughout the world, data have been needed on the effects of the pandemic on various aspects of healthcare systems. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Emergency Service, Hospital, General Surgery
What is being tested?
COVID-19 Pandemic
How many people
10,000 participants
Where
1 siteIsrael
Study dates
5 Apr 2020to 1 Apr 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: All patients aged >18 years old who attended the emergency department of Sheba Medical Center between January 1 - March 31 in the following years: 2017, 2018, 2019, 2020

Who may be able to join

  • All patients visiting the ER of Sheba Medical Center between January 1 - March 31 in the following years: 2017, 2018, 2019, 2020

Who cannot join

  • Patients less than 18 years of age

Trial locations and contacts

1 site in 1 country.

Israel1 site, 1 recruiting
  • Sheba Medical Center

    Ramat Gan

    Roi Anteby, MD, +972545882207, roi.anteby@sheba.health.gov.il

    Recruiting

Other trials in Israel

About this study

Official title: The Impact of the Coronavirus Disease 2019 (Covid-19) Outbreak on Emergency Room Attendances of Surgical Patients at a Tertiary Medical Center

Since December 2019, when the novel coronavirus disease (Covid-19) spread throughout the world, data have been needed on the effects of the pandemic on various aspects of healthcare systems. Recommendations for social distancing and quarantine decrees made by local governments, alongside the general public fear from the spread of the virus, are presumed to have markedly affected the trends in hospitals visits. Understanding the exact nature of the effect is critical for better anticipating and preparing health systems in the event of future outbreaks and in the post outbreak period. Therefore we intend to To identify retrospectively all patients who presented to the emergency department at our medical institute between January 1 - March 31 in the following years: 2017, 2018, 2019, 2020. We will examine the impact of COVID-19 on the rates of surgical emergency visits, ratio of surgical visits to non-surgical visits, the ratio of severe presentations to non-severe presentations, and the impact of age on ED attendance.

Read the detailed description

Since December 2019, when the novel coronavirus disease (Covid-19) spread throughout the world, data have been needed on the effects of the pandemic on various aspects of healthcare systems. Recommendations for social distancing and quarantine decrees made by local governments, alongside the general public fear from the spread of the virus, are presumed to have markedly affected the trends in hospitals visits. Understanding the exact nature of the effect is critical for better anticipating and preparing health systems in the event of future outbreaks and in the post outbreak period. Additionally, deferring hospitals visits can potentially put patients at increased risk for morbidity and mortality, especially in postsurgical patients. Evaluating the impact of the pandemic on patient volume can guide decision-making in future scenarios.

Previous infectious disease outbreaks have been shown to impact ED volumes: The US Hantavirus outbreak in 1993 led to a 2-fold increase in ED visits; Escherichia coli 0157:H7 outbreak in Washington state in 1993 increased ED visits by 17%; However, the 2003 SARS outbreaks in Hong Kong, Taiwan, and Toronto reduced tertiary care ED visits by up to 47 percent.

Being tested
COVID-19 Pandemic
Keywords
Emergency, Surgery, Covid-19
Medical subject headings
Emergencies, COVID-19

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • COVID-19 PandemicOther

    Exposure: the novel coronavirus disease (Covid-19) outbreak

Study groups in NCT04338672
Study groupRoleWhat they receive
Pandemic PeriodPatients who presented to the emergency department at our medical institute Sheba Medical Center between January 1 - March 31 in 2020.
Receives: Other: COVID-19 Pandemic
Pre Pandemic PeriodPatients who presented to the emergency department at our medical institute Sheba Medical Center between January 1 - March 31 in the following years: 2017, 2018, 2019,

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rates of emergency visits needing surgical consult

    Measured: January 1 - March 31 in the following years: 2017, 2018, 2019, 2020

  2. The ratio of severe presentations to non-severe presentations

    Measured: January 1 - March 31 in the following years: 2017, 2018, 2019, 2020

Secondary outcomes (2)
  1. The impact of age on ED attendance rates

    Measured: January 1 - March 31 in the following years: 2017, 2018, 2019, 2020

  2. Differences in ED surgical visits (in terms of capacity and severity) of surgical patients depending on the presentation and the co morbidity

    Measured: January 1 - March 31 in the following years: 2017, 2018, 2019, 2020

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Apr 2020
  2. Study start5 Apr 2020
  3. Primary completion1 Apr 2021 (estimated)
  4. Study completion1 Apr 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
10,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04338672
Sponsor's protocol ID
SMC-20-7078-YZ-CTIL
Status last verified
Apr 2020
First submitted
4 Apr 2020
Last updated
21 Apr 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Heiber M, Lou WY. Effect of the SARS outbreak on visits to a community hospital emergency department. CJEM. 2006 Sep;8(5):323-8. doi: 10.1017/s148180350001397x.

    PubMed 17338843
  • Chen WK, Cheng YC, Chung YT, Lin CC. The impact of the SARS outbreak on an urban emergency department in Taiwan. Med Care. 2005 Feb;43(2):168-72. doi: 10.1097/00005650-200502000-00010.

    PubMed 15655430
  • Anteby R, Zager Y, Barash Y, Nadler R, Cordoba M, Klang E, Klein Y, Ram E, Gutman M, Horesh N. The Impact of the Coronavirus Disease 2019 Outbreak on the Attendance of Patients with Surgical Complaints at a Tertiary Hospital Emergency Department. J Laparoendosc Adv Surg Tech A. 2020 Sep;30(9):1001-1007. doi: 10.1089/lap.2020.0465. Epub 2020 Jun 23.

    PubMed 32589496

Questions about this trial

What is this clinical trial studying?

An observational study of Emergency Service, Hospital and General Surgery, run by Sheba Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 21 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Roi Anteby, MD (19293011120, roi.anteby@sheba.health.gov.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rates of emergency visits needing surgical consult (time frame: January 1 - March 31 in the following years: 2017, 2018, 2019, 2020). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04338672, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Apr 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in